An international research team, led by the University of Bristol, has provided the first clues to understand how the mcr-1 gene protects bacteria from colistin — a ‘last resort’ antibiotic used to treat life-threatening bacterial infections that do not respond to other treatment options.

This post comes from the RSS feed of EurekaAlert, you can find more here!

Written by admin